Trials Sponsors Conditions Drugs Pricing

Conditions

Acne Vulgaris

Keywords

AV Zinc GAGS Serum zinc level

Outcome Measures

Primary Outcomes (1)

Acne vulgaris severity score assessment
Assess the severity score of acne vulgaris symptoms by GAGS(Global Acne Grading System) at baseline, and after 8 weeks. And compare the score between two groups. GAGS scores : 1-18 Mild, 19-30 Moderate
8 weeks

Secondary Outcomes (1)

Biochemical assessment and evaluate the adverse effects
8 weeks

Study Arms (2)

Experimental

ACTIVE COMPARATOR

This arm includes 61 acne vulgaris patients receiving topical retinoids

Dietary Supplement: Zinc sulphate tablet 20 mg

Control

PLACEBO COMPARATOR

This arm includes 61 acne vulgaris patients receiving topical retinoids

Dietary Supplement: Placebo tablet 20 mg

Interventions

Zinc sulphate tablet 20 mgDietary supplement

Zinc sulphate tablet 20 mg daily orally for 8 weeks along with topical retinoids.

Experimental

Placebo tablet 20 mgDietary supplement

Placebo tablet 20 mg daily orally for 8 weeks along with topical retinoids

Control

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age11 Years - 35 Years

Sexall

Healthy VolunteersNo

Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

Newly diagnosed mild and moderate AV patients diagnosed by a dermatologist at the outpatient Department of Dermatology and Venereology,
Age: 11-35 years,

Sponsors & Collaborators

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Otherlead

Study Sites (1)

Basic Science and Paraclinical Science of BSMMU

Dhaka, Bangladesh

MeSH Terms

Conditions

Acne Vulgaris

Interventions

Zinc Sulfate

Condition Hierarchy (Ancestors)

Acneiform EruptionsSkin DiseasesSkin and Connective Tissue DiseasesSebaceous Gland Diseases

Intervention Hierarchy (Ancestors)

SulfatesSulfuric AcidsSulfur AcidsSulfur CompoundsInorganic ChemicalsZinc Compounds

Study Officials

Prof. Md. Sayedur Rahman, MBBS, Mphil, FCPS
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
STUDY CHAIR

Enrollment

122 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: phase 2
Allocation: RANDOMIZED
Masking: DOUBLE
Who Masked: PARTICIPANT, INVESTIGATOR
Purpose: TREATMENT
Intervention Model: PARALLEL
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Principal investigator

Study Record Dates

First Submitted

May 11, 2021

First Posted

May 25, 2021

Study Start

April 27, 2021

Actual (reported)

Effectiveness of Zinc Supplementation With Topical Retinoids in Acne Vulgaris Patients

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Study Arms (2)

Experimental

Control

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Intervention Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (1)

Study Arms (2)

Experimental

Control

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Intervention Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Source record

Locations